RA Capital Management - AN2 THERAPEUTICS INC ownership

AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 39 filers reported holding AN2 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RA Capital Management ownership history of AN2 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$89,264,824
+178.3%
5,551,295
+47.1%
1.76%
+189.9%
Q2 2023$32,074,895
-13.9%
3,773,5170.0%0.61%
-28.1%
Q1 2023$37,244,613
+3.6%
3,773,5170.0%0.84%
+15.6%
Q4 2022$35,961,617
-45.2%
3,773,5170.0%0.73%
-47.9%
Q3 2022$65,584,000
+125.8%
3,773,517
+0.7%
1.40%
+80.5%
Q2 2022$29,050,000
-47.4%
3,748,389
+2.2%
0.78%
-35.7%
Q1 2022$55,257,0003,666,6631.21%
Other shareholders
AN2 THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TCG Crossover Management, LLC 2,678,209$43,065,6006.34%
Octagon Capital Advisors LP 867,575$13,950,6062.14%
RA Capital Management 5,551,295$89,264,8241.76%
Frazier Life Sciences Management, L.P. 1,388,889$22,333,3351.48%
Avidity Partners Management LP 1,089,400$17,517,5520.70%
BVF INC/IL 1,563,963$25,148,5250.68%
Monashee Investment Management LLC 99,495$1,599,8800.67%
Nantahala Capital Management 356,789$5,737,1670.49%
ACUTA CAPITAL PARTNERS, LLC 13,300$213,8640.14%
ADAGE CAPITAL PARTNERS GP, L.L.C. 905,556$14,561,3400.03%
View complete list of AN2 THERAPEUTICS INC shareholders